Pixels & Pills

Entries Tagged as 'Legal Issues'

The Six A’s for Managing Legal Disputes

June 11th, 2010 · 8 Comments · Knowledge, Opinion

Kristie Kuhl, JD, Senior Vice President, Makovsky + Co is a counselor on issues that impact biotechnology, specialty pharma, health-product distribution and medical devices.   She led issues management teams assisting US-based B. Braun in response to hospital-related crises. Kristie also led the Agency team that launched Alexion’s Soliris, [...]

[Read more →]

Tags:·········

How Do You Market Pharma Where DTC is Illegal?

June 2nd, 2010 · 5 Comments · Opinion

This post will continue our week-long theme of “Pharma Without Borders,” which inspects how Pharma companies engage with doctors and patients overseas.
By Russ Ward (@russcward)
Sometimes we forget that DTC is unusual and new in the global pharmaceutical market. But direct-to-consumer (DTC) advertising of prescription drugs is illegal everywhere in the world with two exceptions. The [...]

[Read more →]

Tags:···········

Following Up With Steve Woodruff of Impactiviti

May 14th, 2010 · No Comments · Opinion

This post wraps up our week-long discussion around the topic “What Would the Government Regulate?”
By Jason Brandt (@Jasondmg3)
Last month, Pixels & Pills’ Jennifer Abelson interviewed Steve Woodruff of Impactiviti at the ePharma Summit.
Apart from how utterly TV-presenter smooth both of their voices are – we’re lucky they got into pharma before they were snapped up [...]

[Read more →]

Tags:·············

Healthcare Scares

May 10th, 2010 · No Comments · Opinion

This post continues our week-long theme of government regulation with a discussion on why it’s important for consumers to engage with with Pharma companies.
By Russ Ward (@russcward)
Every one of us has done it at least once.
You come down with some sickness, tally up the symptoms of your malady, and hit the internet. Ten minutes later, [...]

[Read more →]

Tags:············

Pharma’s Bill of Rights

May 10th, 2010 · 5 Comments · Opinion

This post is the first in a week-long series that asks “What would the government regulate?”  We’ll be talking about government concerns, healthcare scares, the impact of reform, and more.
By Sven Larsen (@zemoga)
The FDA needs to let the pharmaceutical industry provide information online. Yes, there’s been plenty of disagreement over exactly how this ought to [...]

[Read more →]

Tags:········

Revolution meets reform: can social media help shrink health disparities in the United States?

April 30th, 2010 · 6 Comments · Knowledge, Trends

By Jim Mittler, PhD, Medical Director (@jim_mittler)

We all know that the social media revolution is happening and it cannot be stopped—this is according to the exponential growth of social media over the past several years. It has fundamentally changed the way in which information is disseminated and the way people communicate throughout the world today. [...]

[Read more →]

Tags:······················

Google Sidewiki: The Dust Settles

April 21st, 2010 · 2 Comments · Opinion

This post continues our week-long theme of communication, with tips and guidelines on how to reach consumer communities.
By Sven Larsen (@zemoga)
What can Google’s Sidewiki teach us, more than six months after its launch?
Perhaps, mostly, that even in the fast-paced world of social media, time will tell – and we should let it.
Opinions were certainly rampant [...]

[Read more →]

Tags:···············

Like Talking to a Wall: Why Pharma Needs to Speak Up

March 11th, 2010 · 2 Comments · News, Opinion

From Mark McCoy
There is a high level of dissatisfaction with our healthcare system these days, which makes pharma companies vulnerable to becoming a target for blame.  It’s hard to believe that even though pharma companies discover and develop the drugs that advance medical treatment, the industry is so vilified that only cigarette makers and big [...]

[Read more →]

Tags:·······

Your Front Row (sort of) Seat at Social Media Week

March 5th, 2010 · No Comments · News

It’s usually never good when someone sends you an e-mail saying “I’ve got you on video.”
Fortunately, when we received an e-mail saying just that, it was all good: Exactly a month ago, it was Social Media Week in New York, where our very own DJ Edgerton spoke on a panel about “Navigating Social Media Technology [...]

[Read more →]

Tags:··············

Steve Woodruff of Impactiviti on eHarmony and the FDA

February 9th, 2010 · 2 Comments · News, Opinion

Live from the E-Pharma Summit (#epharma)
Steve Woodruff  of Impactiviti talks about what it’s like to be the “eHarmony of the Pharmaceutical industry” and why the FDA should stay away from specifics when it comes to social media guidelines.

[Read more →]

Tags:···············